|
|
|
|
 |
News releases
Back to the news list |
 |
February 23, 2010
Æterna Zentaris CEO to Take Part in Panel Discussion on Cancer Therapy at Upcoming RBC Capital Markets Healthcare Conference in New York on March 3
Québec City, Canada, February 23, 2010 - Æterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), (the "Company"), a late-stage drug development company specialized in oncology and endocrinology, today announced that its President and CEO, Juergen Engel, Ph.D., will take part in a panel discussion titled, "Cancer: Improving Treatment through Combination Therapy" at the RBC Capital Markets Healthcare Conference on Wednesday, March 3, 2010, from 8:00 am to 8:55 am (eastern) in the Holmes I Room of The New York Palace Hotel in New York City.
A live audio webcast of the panel discussion will be available in the Investors section of the Company’s website at www.aezsinc.com. A replay of the webcast will also be available on its website for a period of 30 days.
About Æterna Zentaris Inc.
Æterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrinology. News releases and additional information are available at www.aezsinc.com.
Investor Relations
Ginette Vallières
Investor Relations Coordinator
(418) 652-8525 ext. 265
gvallieres@aezsinc.com
Media Relations
Paul Burroughs
Director of Communications
(418) 652-8525 ext. 406
pburroughs@aezsinc.com
-30-
|
|
|
 |
|
|
|
